Diagnosis: Drug photoallergic dermatitis (doxycycline)
A 32-year-old male traveler presents with an itchy pink eruption localized to sun-exposed areas after a week of taking doxycycline for a respiratory infection. Physical examination reveals erythematous papules and patches primarily on the face, neck, and forearms, consistent with a drug-induced photodermatitis due to doxycycline exposure.
A 32-year-old male presents with a one-week history of an itchy pink eruption on sun-exposed areas after starting doxycycline for a respiratory infection. On examination, there are erythematous papules and patches on the face, neck, and forearms, with sparing of non-exposed areas. The lesions are well-defined and exhibit a photosensitive distribution.Age: 32 years oldSex: MaleDuration: 1 weekKey complaint: Itchy rash on sun-exposed areasExam findings: Erythematous papules and patches, well-defined borders
The patient reports that the rash began shortly after starting doxycycline, coinciding with increased sun exposure during his travels. He has no significant past medical history and does not take other medications. There is no family history of skin conditions, and he denies any recent changes in skin care products or new exposures. He has been using sunscreen intermittently but did not apply it consistently during his trip.Onset: Rash began after one week of doxycycline use.Triggers: Increased sun exposure while traveling.Prior treatments: None; this is his first episode.Past medical history: No significant history.Family history: No skin conditions reported.Social history: No recent changes in skin care products.
Acute / First-Line ManagementDiscontinue doxycycline immediately.Topical corticosteroids (e.g., hydrocortisone 1% cream) applied twice daily to affected areas to reduce inflammation.Oral antihistamines (e.g., cetirizine 10 mg daily) for symptomatic relief of itching.Workup and Diagnostic ConfirmationClinical diagnosis based on history and physical examination findings.Patch testing may be considered in atypical cases or if other drug allergies are suspected.Long-Term ManagementEducate the patient on avoiding sun exposure, particularly when taking photosensitizing medications.Advise consistent use of broad-spectrum sunscreen (SPF 30 or higher) when outdoors.Consider alternative antibiotics that do not carry a risk of photosensitivity for future infections.
Polymorphous light eruption: Commonly presents as pruritic papules and plaques in sun-exposed areas, typically occurring in spring/summer, but not associated with medication.Contact dermatitis: Can present similarly, but often has a clear exposure history to an allergen or irritant, and typically involves non-sun-exposed areas.Phototoxic dermatitis: Characterized by a more immediate reaction to UV exposure after medication use, often leading to an exaggerated sunburn-like appearance.Urticaria pigmentosa: A mast cell disorder that can cause itch and lesions, but is usually chronic and not triggered by sun exposure or medications.Exanthematous drug eruption: A generalized rash that may not be confined to sun-exposed areas and typically occurs 1-2 weeks after drug introduction.Chronic actinic dermatitis: Presents with persistent dermatitis in sun-exposed areas but occurs in older adults and has a different clinical history.Seborrheic dermatitis: Commonly affects the scalp and face, but the lesions are usually greasy and not exclusively in sun-exposed areas.Atopic dermatitis: Can present with pruritus and erythematous lesions but is typically associated with a personal or family history of atopy.
High-Yield PearlsPhotosensitivity: Drug-induced photosensitivity can lead to skin eruptions in sun-exposed areas; doxycycline is a known culprit.Discontinuation: Immediate discontinuation of the offending medication is essential for resolution.Topical corticosteroids: Effective in managing inflammation and pruritus associated with drug photoallergic dermatitis.Sun protection: Advise patients on consistent use of broad-spectrum sunscreen to prevent exacerbation during recovery.Patient education: Inform patients of potential photosensitizing effects of medications before prescribing.Always consider drug-induced photosensitivity in patients presenting with dermatitis after starting new medications.
Tags: photodermatitis, doxycycline, drug